Scholars Central

Conference abstractPublished 7 Sep 2016

Modulation of the immune response by peptides derived from enkephalin: Stress and immunity

Authors: Robert C Sizemore

Alcorn State University, USA

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

It has been well established that the immune and neuroendocrine systems interact and communicate with each other. We have demonstrated that methionine-enkephalin (Tyr-Gly-Gly-Phe-Met [YGGFM]) and certain of its peptide derivatives (Tyr-Gly-Gly [YGG] and Tyr-Gly [YG]) modulate immune responses in a biphasic manner with suppression at high doses and enhancement at low concentrations. These data showed in vivo (via DTH responses) and in vitro (via cytokine production) that met-enkephalin, YGG and YG modulated immune responses in a concentration-dependent biphasic manner without affecting the overall number of cells. The di and tri-peptides showed a higher specific activity than the parent molecule with YG being the smallest active moiety. Tyr alone and GGFM were both inactive. Although YG and YGG were more potent than met-enkephalin in immune enhancement, an analog of met-enkephalin resistant to peptidase activity [DADME] enhanced responses but did not induce suppression. Thus, while cleavage of YGGFM to YG may be required for suppression it is not required for immune enhancement. Naloxone (an opioid receptor antagonist) blocked enhancive but not suppressive effects of met-enkephalin. Thus, binding to classical opiate receptors may be involved in the initiation of enhancement by met-enkephalin while cleavage to YG and an unidentified, nonopioid receptor may be associated with suppression. This is consistent with negative feedback such that when the concentration of YG increases, a suppressor mechanism downregulates the response. Thus, these studies may identify a novel mechanism heretofore unrecognized and given that the enkephalins are conserved throughout nature, it may represent one of the oldest means of regulating immune responses in phylogeny.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Clinical Pharmacology & Biopharmaceutics.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalClinical Pharmacology & Biopharmaceutics
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Robert C Sizemore”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels